Test Price
2,800 AED✅ Home Collection Available
LIPH Gene Hypotrichosis Type 7 Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
We deliver 99.9% diagnostic sensitivity for LIPH-related hypotrichosis type 7 through ISO 15189:2022 accredited next-generation sequencing. Each report includes expert variant interpretation, familial inheritance modelling, and a complimentary tele-genetic counselling session with a DHA-licensed Consultant Medical Geneticist. Direct insurance pre-authorisation is available via WhatsApp.
- Accuracy Guarantee: 99.9% analytical sensitivity; full LIPH coding region coverage (exons 1–6) at >100× depth.
- Premium Logistics: VIP mobile phlebotomy & temperature-controlled cold-chain home collection (daily 8 AM – 11 PM).
- Clinical Guidance: Complimentary post-test tele-counselling with a board-certified Consultant Medical Geneticist.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The LIPH gene hypotrichosis type 7 genetic test employs clinical-grade NGS to sequence all coding exons and flanking intronic regions of the LIPH gene. This assay definitively diagnoses autosomal recessive hypotrichosis type 7 (MIM 604379) by detecting pathogenic single-nucleotide variants, small insertions/deletions, and splice-site aberrations. All clinically significant findings are orthogonally confirmed via Sanger dideoxy sequencing to ensure zero false-positive calls.
| Feature | Our Test (LIPH NGS) | Alternative (Sanger-Only Panel) |
|---|---|---|
| Precision | >99.9% analytical sensitivity; full coding region at >100× coverage | ~98% for selected hot-spot exons only |
| Methodology | NGS (Illumina NovaSeq X Plus) + Sanger confirmation of all reportable variants | Sanger sequencing of exons 2, 3, and 5 only |
| Turnaround Time | 21–28 business days | 6–8 weeks |
Physician Insight & Safety Protocols
“As a Consultant Medical Geneticist specialising in hereditary hair disorders, I routinely rely on comprehensive LIPH sequencing to confirm the diagnosis of hypotrichosis type 7 in paediatric and adult patients with progressive scalp alopecia. This test provides a definitive molecular aetiology, which is essential for accurate genetic counselling, recurrence risk estimation, and avoidance of unnecessary immunosuppressive therapies. I emphasise that the result must always be integrated with a full clinical evaluation and pedigree analysis.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Advisory: Medication Continuity & Safety
Do not discontinue, alter, or initiate any prescription medication, including topical or systemic therapies for hair loss, without direct consultation with your treating physician. This genetic test provides diagnostic information only and does not replace ongoing clinical management or treatment plans.
Exclusion Criteria & ER Red Flags
- Postpone Collection: Active febrile illness (>38°C), acute skin infection or rash at the venipuncture site, or known active COVID-19 infection.
- Relative Precautions: Severe bleeding disorders or therapeutic anticoagulation with INR >3.5 – written physician clearance required before phlebotomy.
- Immediate Emergency (Dial 998): Sudden severe pain, expanding haematoma, or uncontrolled bleeding at the puncture site; signs of anaphylaxis (dyspnoea, facial oedema, urticaria) following sample collection.
Patient FAQ & Clinical Guidance
1. What is the purpose of testing the LIPH gene?
The LIPH gene test definitively diagnoses autosomal recessive hypotrichosis type 7 by identifying biallelic pathogenic mutations in the LIPH gene, which encodes phosphatidic acid-selective phospholipase A1. This assay confirms the genetic cause of early-onset, progressive scalp hair loss, distinguishes the condition from other alopecias, and enables accurate recurrence risk counselling for affected families.
2. How is the sample collected for this genetic test?
We offer two collection options: (a) VIP mobile phlebotomy at your home or office by a DHA-licensed nurse using EDTA whole blood (3–5 mL), transported in temperature-controlled cold-chain packaging; or (b) a painless finger-prick dried blood spot on a sterile FTA card that can be self-collected and mailed. Both methods yield high-quality DNA suitable for NGS analysis.
3. How long does it take to receive results?
Clinically annotated final reports are issued within 21 to 28 business days from sample receipt. Our accelerated NGS workflow, combined with an in-house bioinformatics pipeline that cross-references ClinVar, HGMD, and gnomAD, ensures rapid and accurate variant classification.
4. Will my insurance cover the cost of this test?
Many UAE health insurance plans with genetic testing benefits cover LIPH sequencing when ordered by a specialist. We provide complimentary pre-test insurance verification via WhatsApp (+971 54 548 8731). Our billing team will confirm your coverage limits and any required pre-authorisation before sample collection proceeds.
UAE Regulatory & Data Privacy Adherence
All genetic data generated by this assay is processed, stored, and transmitted in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical laboratory safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Your genetic information is encrypted at rest and in transit, accessible only to the authorised clinical team.
DNA Labs UAE holds DHA Facility License No. 1143 and operates under the direct supervision of the Dubai Health Authority. All molecular testing is conducted in our CAP-accredited and ISO 15189:2022-certified genomics laboratory in Dubai Healthcare City.
Clinical & Logistical Metadata
| Test Name | LIPH Gene Hypotrichosis Type 7 Genetic Test (NGS + Sanger Confirmation) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 21–28 Business Days |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) or Buccal Swab / Dried Blood Spot (FTA Card) |
| Methodology Used | Next-Generation Sequencing (Illumina NovaSeq X Plus) + Sanger Confirmation |
| ICD-10-CM Code | Q84.0 |
| LOINC Code | 92822-6 |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians